Interpace Biosciences, Inc.
USD1.63
-0.05 (-2.98%)
CEO
Thomas W. Burnell
IPO Date
1998-05-20
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
OTC
Country
US
Open
$1.71
Prev. Close
$1.68
Day Low
$1.63
Day High
$1.80
52W Low
$0.75
52W High
$2.40
Market Cap
$0.05B
Volume
0.02M
| 1.8 |
| 31 Dec 2023 | FY | 59.4% | 2.0% | -5.3% | 6.2% | -0.74 | 0.59 | 5.8 |
| 31 Dec 2022 | FY | 57.3% | -18.4% | 9.3% | -36.7% | -0.26 | 0.85 | -0.8 |
| 31 Dec 2021 | FY | 43.4% | -35.7% | 34.8% | -38.4% | -0.32 | 0.78 | -2.1 |
| 31 Dec 2020 | FY | 33.1% | -80.9% | 90.1% | -57.4% | -0.16 | 0.77 | -0.5 |
| 31 Dec 2019 | FY | 34.0% | -110.6% | -204.5% | -38.6% | 0.54 | 0.95 | -0.7 |
| 31 Dec 2018 | FY | 53.4% | -55.7% | -37.0% | -25.2% | 0.00 | 2.09 | -1.8 |
| 31 Dec 2017 | FY | 53.7% | -76.8% | -30.6% | -22.8% | 0.00 | 2.48 | -1.3 |
| 31 Dec 2016 | FY | 49.2% | -63.7% | -127.6% | -19.9% | 1.21 | 0.26 | -4.4 |
| 0.1 |
| 30 Sept 2025 | Q3 | 62.1% | 10.4% | -305.7% | 7.6% | -7.58 | 1.54 | 1.1 |
| 30 Jun 2025 | Q2 | 57.1% | -6.9% | 52.8% | -5.2% | -2.60 | 1.33 | -1.3 |
| 31 Mar 2025 | Q1 | 64.0% | 14.3% | -283.0% | 11.4% | -7.28 | 1.34 | 0.6 |
| 31 Dec 2024 | Q4 | 72.4% | 23.5% | -130.4% | 19.6% | -2.64 | 1.11 | 1.0 |
| 30 Sept 2024 | Q3 | 61.0% | 10.4% | -11.5% | 9.1% | -0.64 | 0.59 | 1.5 |
| 30 Jun 2024 | Q2 | 61.7% | 17.1% | -16.5% | 15.9% | -0.67 | 0.53 | 0.6 |
| 31 Mar 2024 | Q1 | 59.1% | 4.6% | -3.2% | 3.9% | -0.72 | 0.50 | 3.2 |
| 31 Dec 2023 | Q4 | 59.4% | 8.7% | -5.9% | 6.8% | -0.74 | 0.59 | 1.3 |